EDITAS MEDICINE, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- EDITAS MEDICINE, INC. stock issued during period, value, new issues for the quarter ending 2026-06-30 was $116.88M, a 1526.72% increase year-over-year.
- EDITAS MEDICINE, INC. stock issued during period, value, new issues for the quarter ending 2025-09-30 was $17.15M.
- EDITAS MEDICINE, INC. stock issued during period, value, new issues for the quarter ending 2025-06-30 was $7.18M.
- EDITAS MEDICINE, INC. stock issued during period, value, new issues for the quarter ending 2025-03-31 was $1.44M.
- EDITAS MEDICINE, INC. stock issued during period, value, new issues for fiscal 2025 was $42.85M.
- EDITAS MEDICINE, INC. stock issued during period, value, new issues for fiscal 2023 was $117.08M.
- EDITAS MEDICINE, INC. stock issued during period, value, new issues for fiscal 2021 was $249.46M, a 22.45% increase from fiscal 2020.
- EDITAS MEDICINE, INC. stock issued during period, value, new issues for fiscal 2020 was $203.73M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-06-30 | $116.88M 10-Q · filed 2026-08-05 | |
| 2025-12-31 | $42.85M 10-K · filed 2026-03-09 | |
| 2025-09-30 | $17.15M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $7.18M 10-Q · filed 2026-08-05 | |
| 2025-03-31 | $1.44M 10-Q · filed 2026-08-05 | |
| 2023-12-31 | $117.08M 10-K · filed 2025-03-05 | |
| 2023-06-30 | $117.08M 10-Q · filed 2024-11-04 | |
| 2021-12-31 | $249.46M 10-K · filed 2024-02-28 | |
| 2021-03-31 | $249.46M 10-Q · filed 2022-11-02 | |
| 2020-12-31 | $203.73M 10-K · filed 2023-02-22 | |
| 2020-06-30 | $203.68M 10-Q · filed 2021-11-09 | |
| 2019-09-30 | $41.99M 10-Q · filed 2020-11-06 | |
| 2018-03-31 | $48.49M 10-Q · filed 2019-11-12 | |
| 2016-12-31 | $97.49M 10-K · filed 2018-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |